KalVista Pharmaceuticals, Inc.
KALV · NASDAQ
9/30/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$49 | -$60 | -$52 | -$49 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $6 | $0 | -$9 | $3 |
| Change in WC | $5 | -$5 | $19 | $6 |
| Other Non-Cash | $6 | $10 | $1 | $7 |
| Operating Cash Flow | -$33 | -$55 | -$40 | -$33 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | $0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$20 | $38 | -$7 |
| Inv. Sales/Matur. | $0 | $42 | $21 | $15 |
| Other Inv. Act. | $9 | -$0 | -$63 | -$0 |
| Investing Cash Flow | $9 | $21 | -$3 | $9 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $22 | $3 | $0 |
| Stock Issued | $0 | $1 | $2 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $152 | $0 | $0 | $152 |
| Financing Cash Flow | $152 | $23 | $5 | $152 |
| Forex Effect | -$1 | $3 | $3 | -$1 |
| Net Chg. in Cash | $126 | -$7 | -$36 | $126 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $42 | $132 | $168 | $42 |
| End Cash | $168 | $124 | $132 | $168 |
| Free Cash Flow | -$33 | -$55 | -$40 | -$33 |